Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310668159> ?p ?o ?g. }
- W4310668159 endingPage "470" @default.
- W4310668159 startingPage "458" @default.
- W4310668159 abstract "This work describes Part 2 of multi-dose formulation development of a Human Papillomavirus (HPV) Virus-Like Particle (VLP) based vaccine (see Part 1 in companion paper). Storage stability studies with candidate multi-dose formulations containing individual or combinations of seven different antimicrobial preservatives (APs) were performed with quadrivalent HPV VLP (6, 11, 16, 18) antigens adsorbed to aluminum-salt adjuvant (Alhydrogel®). Real-time (up to two years, 2-8°C) and accelerated (months at 25 and 40°C) stability studies identified eight lead candidates as measured by antigen stability (competitive ELISA employing conformational serotype-specific mAbs), antimicrobial effectiveness (modified European Pharmacopeia assay), total protein content (SDS-PAGE), and AP concentration (RP-UHPLC). The AH-adsorbed HPV18 VLP component was most sensitive to AP-induced destabilization. Optimal quadrivalent antigen storage stability while maintaining antimicrobial effectiveness was observed with 2-phenoxyethanol, benzyl alcohol, chlorobutanol, and 2-phenoxyethanol + benzyl alcohol combination. Interestingly, for single-AP containing multi-dose formulations, this rank-ordering of storage stability did not correlate with previously reported biophysical measurements of AP-induced antigen destabilization. Moreover, other APs (e.g., m-cresol, phenol, parabens) described by others for inclusion in multi-dose HPV VLP formulations showed suboptimal stability. These results suggest that each HPV VLP vaccine candidate (e.g., different serotypes, expression systems, processes, adjuvants) will require customized multi-dose formulation development." @default.
- W4310668159 created "2022-12-15" @default.
- W4310668159 creator A5005091169 @default.
- W4310668159 creator A5008194289 @default.
- W4310668159 creator A5013065825 @default.
- W4310668159 creator A5017925928 @default.
- W4310668159 creator A5018097676 @default.
- W4310668159 creator A5019976375 @default.
- W4310668159 creator A5026833623 @default.
- W4310668159 creator A5028003165 @default.
- W4310668159 creator A5035149462 @default.
- W4310668159 creator A5043166283 @default.
- W4310668159 creator A5063380862 @default.
- W4310668159 creator A5065112517 @default.
- W4310668159 creator A5070321614 @default.
- W4310668159 creator A5072784089 @default.
- W4310668159 creator A5073302681 @default.
- W4310668159 creator A5075522646 @default.
- W4310668159 creator A5091793372 @default.
- W4310668159 date "2023-02-01" @default.
- W4310668159 modified "2023-09-26" @default.
- W4310668159 title "Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies" @default.
- W4310668159 cites W1967525776 @default.
- W4310668159 cites W1973540262 @default.
- W4310668159 cites W1974011507 @default.
- W4310668159 cites W1981076153 @default.
- W4310668159 cites W2010286031 @default.
- W4310668159 cites W2011786173 @default.
- W4310668159 cites W2014837879 @default.
- W4310668159 cites W2021536429 @default.
- W4310668159 cites W2034532448 @default.
- W4310668159 cites W2046077398 @default.
- W4310668159 cites W2070642362 @default.
- W4310668159 cites W2079910321 @default.
- W4310668159 cites W2091279113 @default.
- W4310668159 cites W2091775298 @default.
- W4310668159 cites W2100800584 @default.
- W4310668159 cites W2101781338 @default.
- W4310668159 cites W2110252570 @default.
- W4310668159 cites W2114031476 @default.
- W4310668159 cites W2155451445 @default.
- W4310668159 cites W2162320594 @default.
- W4310668159 cites W2338720989 @default.
- W4310668159 cites W2584855429 @default.
- W4310668159 cites W2587904144 @default.
- W4310668159 cites W2806356939 @default.
- W4310668159 cites W2895493756 @default.
- W4310668159 cites W2946893685 @default.
- W4310668159 cites W2955245499 @default.
- W4310668159 cites W2983406127 @default.
- W4310668159 cites W3082261970 @default.
- W4310668159 cites W3109215073 @default.
- W4310668159 cites W4288809661 @default.
- W4310668159 doi "https://doi.org/10.1016/j.xphs.2022.11.021" @default.
- W4310668159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36462710" @default.
- W4310668159 hasPublicationYear "2023" @default.
- W4310668159 type Work @default.
- W4310668159 citedByCount "3" @default.
- W4310668159 countsByYear W43106681592022 @default.
- W4310668159 countsByYear W43106681592023 @default.
- W4310668159 crossrefType "journal-article" @default.
- W4310668159 hasAuthorship W4310668159A5005091169 @default.
- W4310668159 hasAuthorship W4310668159A5008194289 @default.
- W4310668159 hasAuthorship W4310668159A5013065825 @default.
- W4310668159 hasAuthorship W4310668159A5017925928 @default.
- W4310668159 hasAuthorship W4310668159A5018097676 @default.
- W4310668159 hasAuthorship W4310668159A5019976375 @default.
- W4310668159 hasAuthorship W4310668159A5026833623 @default.
- W4310668159 hasAuthorship W4310668159A5028003165 @default.
- W4310668159 hasAuthorship W4310668159A5035149462 @default.
- W4310668159 hasAuthorship W4310668159A5043166283 @default.
- W4310668159 hasAuthorship W4310668159A5063380862 @default.
- W4310668159 hasAuthorship W4310668159A5065112517 @default.
- W4310668159 hasAuthorship W4310668159A5070321614 @default.
- W4310668159 hasAuthorship W4310668159A5072784089 @default.
- W4310668159 hasAuthorship W4310668159A5073302681 @default.
- W4310668159 hasAuthorship W4310668159A5075522646 @default.
- W4310668159 hasAuthorship W4310668159A5091793372 @default.
- W4310668159 hasBestOaLocation W43106681591 @default.
- W4310668159 hasConcept C147483822 @default.
- W4310668159 hasConcept C159047783 @default.
- W4310668159 hasConcept C161790260 @default.
- W4310668159 hasConcept C178790620 @default.
- W4310668159 hasConcept C185592680 @default.
- W4310668159 hasConcept C203014093 @default.
- W4310668159 hasConcept C2776460118 @default.
- W4310668159 hasConcept C2777863537 @default.
- W4310668159 hasConcept C43617362 @default.
- W4310668159 hasConcept C4937899 @default.
- W4310668159 hasConcept C55493867 @default.
- W4310668159 hasConcept C86803240 @default.
- W4310668159 hasConcept C89423630 @default.
- W4310668159 hasConceptScore W4310668159C147483822 @default.
- W4310668159 hasConceptScore W4310668159C159047783 @default.
- W4310668159 hasConceptScore W4310668159C161790260 @default.
- W4310668159 hasConceptScore W4310668159C178790620 @default.
- W4310668159 hasConceptScore W4310668159C185592680 @default.
- W4310668159 hasConceptScore W4310668159C203014093 @default.